Tech Company Financing Transactions
Tizona Therapeutics Funding Round
MPM Capital and private investors participated in a $13.5 million venture round for Tizona Therapeutics. This venture round was announced on 9/30/2015.
Transaction Overview
Company Name
Announced On
9/30/2015
Transaction Type
Venture Equity
Amount
$13,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4000 Shoreline Ct. 200
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Tizona Therapeutics, Inc. is a preclinical stage biotechnology company that is developing multiple, innovative immuno-oncology therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Luke Evnin
Vice President
Courtney Beers
Vice President
John Corbin
VP - Bus. Development
Svetlana Lucas
VP - Operations
Christine O'Brien
Browse more venture capital transactions:
Prev: 9/30/2015: OverDog venture capital transaction
Next: 9/30/2015: Lendio venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs